Curis to Present at the RBC Capital Markets Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the RBC Capital Markets Healthcare Conference at 10:00 a.m. EST on March 3, 2011, in New York City. Dan Passeri, Curis’ President and Chief Executive …

Via:Read more on Business Wire